Simplex Trading, LLC Fulcrum Therapeutics, Inc. Transaction History
Simplex Trading, LLC
- $175 Billion
- Q2 2025
A detailed history of Simplex Trading, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 109,365 shares of FULC stock, worth $748,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,365
Previous 3,026
3514.18%
Holding current value
$748,056
Previous $8,000
9300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding FULC
# of Institutions
123Shares Held
52MCall Options Held
48.9KPut Options Held
13.8K-
Ra Capital Management, L.P. Boston, MA10.2MShares$70 Million0.61% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$35.9 Million3.64% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.07MShares$34.7 Million0.64% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.82MShares$33 Million0.63% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$32.8 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $356M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...